Hemophagocytic syndrome after highly active antiretroviral therapy initiation: A life-threatening event related to immune restoration inflammatory syndrome?

AIDS

Volumn 22, Issue 4, 2008, Pages 549-551

  Cuttelod, Melanie ^a   Pascual, Andres ^a   Baur Chaubert, Audrey S ^b   Cometta, Alain ^c   Osih, Regina ^a   Duchosal, Michel A ^a   Cavassini, Matthias ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; COTRIMOXAZOLE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EFAVIRENZ; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISONE; TENOFOVIR; VINBLASTINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; HEMOPHAGOCYTIC SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LABORATORY TEST; LETTER; MALE; PALLIATIVE THERAPY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFLAMMATORY AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HODGKIN DISEASE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PREDNISONE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 39849094719     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f4a0fd     Document Type: Letter

References (12)

1. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6:601-608.
2. Dawson L, den Ottolander GJ, Kluin PM, Leeksma O. Reactive hemophagocytic syndrome as a presenting feature of Hodgkin's disease. Ann Hematol 2000; 79:322-326.
3. Kojima H, Takei N, Mukai Y, Hasegawa Y, Suzukawa K, Nagata M, et al. Hemophagocytic syndrome as the primary clinical symptom of Hodgkin's disease. Ann Hematol 2003; 82:53-56.
4. Castilletti C, Preziosi R, Bernardini G, Caterini A, Gomes V, Calcaterra S, et al. Hemophagocytic syndrome in a patient with acute human immunodeficiency virus infection. Clin Infect Dis 2004; 38:1792-1793.
5. Sproat LO, Pantanowitz L, Lu CM, Dezube BJ. Human immunodeficiency virus-associated hemophagocytosis with irondeficiency anemia and massive splenomegaly. Clin Infect Dis 2003; 37:E170-E173.
6. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005; 135 (21-22):299-314.
7. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18:1615-1627.
8. Dean GL, Williams DI, Churchill DR, Fisher MJ. Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome. Am J Respir Crit Care Med 2002; 165:1670.
9. Koval CE, Gigliotti F, Nevins D, Demeter LM. Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 2002; 35:491-493.
10. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133:447-454.
11. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006; 57:167-170.
12. Huang DB, Wu JJ, Hamill RJ. Reactive hemophagocytosis associated with the initiation of highly active antiretroviral therapy (HAART) in a patient with AIDS. Scand J Infect Dis 2004; 36 (6-7):516-519.